Voya Investment Management LLC Concert Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $140,609 - $195,436	-37,297 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $116,547 - $313,431	23,981 Added 180.09%	37,297 $186,000
Q4 2020 Feb 16, 2021	BUY	$9.48 - $12.84 $30,648 - $41,511	3,233 Added 32.06%	13,316 $168,000
Q2 2020 Aug 14, 2020	SELL	$7.8 - $11.52 $23,220 - $34,295	-2,977 Reduced 22.79%	10,083 $100,000
Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $7,887 - $17,265	1,319 Added 11.23%	13,060 $115,000
Q4 2019 Feb 14, 2020	BUY	$5.71 - $9.22 $67,041 - $108,252	11,741 New	11,741 $108,000
Q2 2018 Aug 14, 2018	SELL	$16.83 - $21.66 $147,733 - $190,131	-8,778 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $122,540 - $255,000	8,778	8,778 $227,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.